Addressing Biosecurity Barriers in High-Risk Biological Research

David R Gillum1, Randy A Albrecht1, Rebecca Caruso1

  • 1David R. Gillum, PhD, is Associate Vice President, Compliance and Research Administration, University of Nevada, Reno, and Co-Founder, Tutela Strategies, LLC.; both in Reno, NV. Randy A. Albrecht, PhD, is Senior Director, Biosafety, Icahn School of Medicine at Mount Sinai, New York, NY. Rebecca Caruso, MPH, is Director, Committee on Microbiological Safety, Office of Biological Safety, Harvard Medical School, Boston, MA. Amanda Craigen is Biological Safety Officer, Environmental Health and Safety, University of North Carolina, Chapel Hill, NC. Lesley Decker, MS, is a Biosafety Manager, Environmental Health and Safety, University of Washington, Seattle, WA. Haley L. DeMers, PhD, is Director, BSL-3 Training Program, University of California, Irvine, Irvine, CA. Colleen Driskill is Director of Biosafety and Select Agent Responsible Official, University of Massachusetts Chan Medical School, Worcester, MA. Robert Foreman, PhD, is Biosafety Officer, Research Safety, Northwestern University, Chicago, IL. Deborah Howard, MPH, Expert, Global Environment, Environment Health and Safety, BASF Corporation, Durham, NC. Barbara Johnson, PhD, is Owner, Biosafety Biosecurity International, Merritt Island, FL. Jens H. Kuhn, PhD, is Principal Scientist and Director of Virology (Tunnell Government Services Contractor), Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD. Yong-Bee Lim, PhD, is Associate Director, Global Risk, Federation of American Scientists, Washington, DC. Rebecca L. Moritz, MS, is Co-Founder, Tutela Strategies, LLC, Reno, NV. Corrie Ntiforo, MSPH, is Director, Department of Biosafety, University of Texas Medical Branch; Galveston, TX. Luis Alberto Ochoa Carrera is High-Containment Lab and Pandemic Safety Manager, Environmental Health and Safety Office, Michigan State University, Lansing, MI. Gregory Park, PhD, is Director, Office of Biotechnology Activities Oversight, University of Minnesota, Minneapolis, MN. Christina L. Pier, MS, is a Select Agent Responsible Official, Environment, Health, and Safety, University of Wisconsin, Madison, WI. Antony Schwartz, PhD, is Director, Biological Safety Division, Occupational and Environmental Safety Office, Duke University, Durham, NC. Adrian Self is Operations Research Analyst, National Agricultural Biosecurity Center, Kansas State University, Manhattan, KS. Megan Shoff, PhD, is Institutional Biosafety Program Manager and Animal Biological Safety Officer, Research Compliance and Biosafety, Texas A&M University, College Station, TX. Paul Skoglund, PhD, is Institutional Biosafety Committee Coordinator, Environmental Health and Safety, University of Virginia, Charlottesville, VA. Mary Turlington-Powell, MS, Director, Biosafety and Biosecurity, and Kathleen M. Vogel, PhD, is Associate Dean and Professor, School for the Future of Innovation in Society, College of Global Futures; both at Arizona State University, Tempe, AZ. Hsiang-Ming Wang, PhD, is Director, Environmental Health and Safety, Texas Biomedical Research Institute, San Antonio, TX.

Health Security
|June 8, 2026
PubMed
Summary

Biological research faces increasing regulatory hurdles that may hinder pandemic preparedness. Experts recommend integrating biosafety expertise into policy and ensuring consistent funding to balance risk reduction with scientific advancement.

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...